Company news

Pharma Foods International Co., Ltd. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

(Progress of Disclosed Matter) Notice Regarding Completion of Acquisition of Shares of Marine Pro Foods Co., Ltd. (to Make It a Subsidiary)

October 30, 2026

Notice Regarding the Execution of an Overdraft Facility Agreement

October 26, 2026

［Summary］Notice Regarding the New Medium-Term Management Plan 2029 "1K Project-SPRING Strategy"

October 16, 2026

Notice Regarding Acquisition of Shares of Marine Pro Foods Co., Ltd. (to Make It a Subsidiary)

October 6, 2026

Supplementary Materials of FY26 Q4 Consolidated Financial Results

September 28, 2026

【 Correction of Numerical Data】Consolidated Financial Results for the Fiscal Year Ended July 31, 2026 (Under Japanese GAAP)

September 17, 2026

[Summary] Consolidated Financial Results for the Fiscal Year Ended July 31, 2026 (Under Japanese GAAP)

September 11, 2026

Notice Regarding Revision of Full-Year Financial Results Forecast for the Fiscal Year Ended July 2026

September 8, 2026

[Summary] Consolidated Financial Results for the Nine Months Ended April 30, 2026 (Under Japanese GAAP)

June 10, 2026

April 30, 2026 Research and Development PharmaGABA® New Scientific Study Published in Leading International Journal - Accelerating Global Expansion and Adoption in the Food & Beverage Category

April 29, 2026

April 6, 2026 Research and Development Pharma Foods Co., Ltd. Acquires Exclusive Rights to Advance First-in-Class Adrenomedullin Program for CADASIL Across Key Asian Markets

April 5, 2026

March 23, 2026 Investor Supplementary Materials of Consolidated Financial Results for the Six Months Ended January 31, 2026

March 23, 2026

February 16, 2026 Investor Notice Concerning Dividends of Surplus (Interim Dividend)

February 16, 2026

December 11, 2025 Investor Supplementary Materials of Consolidated Financial Results for the Three Months Ended October 31 2025

December 10, 2025

December 11, 2025 Investor Consolidated Financial Results for the Three Months Ended October 31, 2025 (Under Japanese GAAP)

December 10, 2025

November 13, 2025 Research and Development Pharma Foods Partners with The University of Tokyo For Next-Generation Antibody Drug Discovery ～A Leap Forward with AI and Advanced Molecular Engineering～

November 12, 2025

September 30, 2025 Investor Notice of the 28th Annual General Meeting of Shareholders

September 29, 2025

September 25, 2025 Investor Consolidated Financial Results for the Year Ended July 31, 2025 (Based on Japanese GAAP)

September 25, 2025

September 24, 2025 Research and Development “ALAgene® technology”-Derived Antibody Therapeutic Candidate Achieves Phase I Clinical Milestone ～Driving Future Growth through Strategic License Agreement～

September 24, 2025

September 19, 2025 Investor Notice Regarding the Board of Directors’ Opinion on a Shareholder Proposal

September 19, 2025

September 19, 2025 Investor Notice Regarding Partial Amendments to the Articles of Incorporation

September 19, 2025

September 11, 2025 Investor Consolidated Financial Results for the Fiscal Year Ended July 31, 2025 (Under Japanese GAAP)

September 11, 2025

September 4, 2025 Investor Notice Regarding Execution of Loan Agreement with Financial Covenants

September 3, 2025

August 19, 2025 Investor Notice Regarding Construction of a New Plant by Our Consolidated Subsidiary and Execution of a Loan Agreement with Financial Covenants

August 18, 2025

July 16, 2025 Research and Development Pharma Foods’ Antibody Technology Advances as Takeda Exercises Sequence Purchase Option

July 15, 2025

June 16, 2025 Investor Notice Regarding Construction of a New Plant by Our Consolidated Subsidiary and Execution of a Loan Agreement with Financial Covenants

June 16, 2025

June 10, 2025 Investor Supplementary Materials of Consolidated Financial Results for the Nine Months Ended April 30, 2025

June 10, 2025

June 10, 2025 Investor Consolidated Financial Results for the Nine Months Ended April 30, 2025 (Under Japanese GAAP)

June 10, 2025

May 14, 2025 Investor Notice Concerning Results of Acquisition of Own Shares Through Off-Auction Own Share Repurchase Trading System (ToSTNeT-3)

May 13, 2025

May 13, 2025 Investor Notice Concerning Acquisition of Own Shares and Repurchase of Own Shares Through Off-Auction Own Share Repurchase Trading System (ToSTNeT-3)

May 13, 2025

February 12, 2025 Research and Development The establishment of World's first "CADASIL Drug Discovery Research Department" in collaboration with National Cerebral and Cardiovascular Center

February 11, 2025

December 13, 2024 Investor (Delayed)Summary of Consolidated Financial Results for the Three Months Ended October 31, 2024 (Based on Japanese GAAP)

December 12, 2024

September 30, 2024 Investor Notice of the 27th Annual General Meeting of Shareholders

September 29, 2024

September 27, 2024 Investor (Delayed) Summary of Consolidated Financial Results for the Year Ended July 31, 2024 (Based on Japanese GAAP)

September 27, 2024

Decks

The 5 newest of 37 decks. Every deck is listed under its year.